We are live on ! Find out more
CMRX

Chimerix, Inc.

Delisted

CMRX was delisted on the 17th of April, 2025.

108 hedge funds and large institutions have $96.5M invested in Chimerix, Inc. in 2022 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

506% more call options, than puts

Call options by funds: $218K | Put options by funds: $36K

27% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 33

1% less capital invested

Capital invested by funds: $97.2M → $96.5M (-$768K)

8% less funds holding

Funds holding: 118108 (-10)

35% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 26

Holders
108
Holders Change
-10
Holders Change %
-8.47%
% of All Funds
1.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
42
Reduced
33
Closed
26
Calls
$218K
Puts
$36K
Net Calls
+$182K
Net Calls Change
-$411K
Name Holding Trade Value Shares
Change
Change in
Stake
RCMNY
1
Rubric Capital Management (New York)
New York
$13.9M +$1.71M +875,000 +13%
BlackRock
2
BlackRock
New York
$9.36M -$1.43M -733,211 -13%
Vanguard Group
3
Vanguard Group
Pennsylvania
$7.87M -$504K -257,835 -6%
AC
4
Armistice Capital
New York
$5.95M +$869K +444,000 +16%
Citadel Advisors
5
Citadel Advisors
Florida
$5.22M +$144K +73,845 +3%
State Street
6
State Street
Massachusetts
$4.34M -$1.14M -580,463 -20%
MAM
7
Monaco Asset Management
Monaco
$4.3M +$380K +194,439 +9%
MP
8
MSD Partners
New York
$3.72M
AQR Capital Management
9
AQR Capital Management
Connecticut
$3.14M +$2.94M +1,504,714 +819%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$2.92M +$49K +25,055 +2%
Jacobs Levy Equity Management
11
Jacobs Levy Equity Management
New Jersey
$2.82M +$2.72M +1,387,961 +1,066%
Millennium Management
12
Millennium Management
New York
$2.4M -$5.27M -2,691,954 -68%
Goldman Sachs
13
Goldman Sachs
New York
$2.32M +$424K +216,671 +21%
NLVP
14
New Leaf Venture Partners
New York
$2.28M
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
$1.94M +$2.04M +1,042,440 New
PAMS
16
Pictet Asset Management (Switzerland)
Switzerland
$1.85M +$476K +243,395 +32%
Morgan Stanley
17
Morgan Stanley
New York
$1.44M -$73K -37,297 -5%
Northern Trust
18
Northern Trust
Illinois
$1.32M -$159K -81,460 -10%
Barclays
19
Barclays
United Kingdom
$1.26M +$491K +251,128 +59%
Renaissance Technologies
20
Renaissance Technologies
New York
$1.22M +$379K +193,686 +42%
D.E. Shaw & Co
21
D.E. Shaw & Co
New York
$1.21M -$226K -115,528 -15%
Two Sigma Investments
22
Two Sigma Investments
New York
$1.16M +$159K +81,074 +15%
Bank of America
23
Bank of America
North Carolina
$1.05M +$446K +228,005 +67%
CS
24
Credit Suisse
Switzerland
$975K -$191K -97,506 -16%
JP Morgan Chase
25
JP Morgan Chase
New York
$916K +$867K +443,188 +895%

CMRX Hedge Fund Activity: Q4 2022 in Review

108 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Chimerix, Inc. (CMRX) for Q4 2022, worth a combined $96.5M — down 0.79% from $97.2M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of CMRX and 17 opened new positions — a net loss of 9 holders — while 33 trimmed existing stakes and 42 added.

The largest buyer was AQR Capital Management, adding an estimated $2.94M. The largest seller was Millennium Management, cutting an estimated $5.27M.

  • 108 institutional investors held Chimerix, Inc. (CMRX) as of Q4 2022, down from 118 in Q3 2022.
  • Funds reported $96.5M of Chimerix, Inc. stock for Q4 2022, down 0.79% quarter-over-quarter.
  • 17 funds opened new Chimerix, Inc. positions in Q4 2022 and 26 closed out, a net change of -9 holders.
  • The largest Chimerix, Inc. buyer in Q4 2022 was AQR Capital Management, an estimated $2.94M added.
  • The largest Chimerix, Inc. seller in Q4 2022 was Millennium Management, an estimated $5.27M sold.

Based on aggregated 13F filings for Q4 2022.